ClinicalTrials.gg
CompletedNCT06551558REGLOUpdated Sep 29, 2026

Impact of a Global Warming Strategy of the Patient on the Prevalence of Hypothermia in the Recovering Room

An interventional study of global warming and per operative warming in Hypothermia; Anesthesia and Perioperative/Postoperative Complications, sponsored by Poitiers University Hospital. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Poitiers University Hospital · Not applicable, Interventional, and Prevention

Updated Sep 29, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
174
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 27 studies in Hypothermia with a site in France — 2 open to participants now, 4 under way, none of them phase 3. Hypothermia · France.

Enrollment
7th of 17
174 · median 116
Started
2024
the only one that year
No phase
13 of 27
1 open now
Registered
25th of 27
by date
Lead sponsor
1 of 27
Poitiers University Hospital

Among the 27 studies in Hypothermia with a site in France, this one is the 7th largest by enrollment of the 17 interventional ones that give a count, is the only one that started in 2024, is one of 13 with no phase, and was the 25th registered.

Hypothermia

450 studies on the registry are indexed under Hypothermia; 53 are open to participants now.

Browse Hypothermia studies →

Open to participants now

2 of the 27 studies in Hypothermia with a site in France are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 27 Hypothermia studies recruiting now, 13 (48%) set no upper age limit and 12 (44%) stop at 75 or younger; 12 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Hypothermia with a site in France, or all of them as a file.
02

Study summary

50% of patients are hypothermic when they arrive in the recovery room. This hypothermia is potentially at risk for the patient (increases bleeding, risk of infection, risk of cardiac involvement, morbid mortality) and 33,2% steel hypothermic when they discharge from the recovering room. The anesthesia team must prevent these risks through prevention and treatment measures. Currently the majority of patient warming is done only in the operating room, we want to measure the impact of the extension of this warming before and after the surgery on the patient's temperature and on side effects related to hypothermia.

Read the detailed description

Hypothermia is defined as a core temperature below 36°C. It is classified by severity stage. A temperature below 36°C is mild hypothermia, below 35°C moderate hypothermia and below 34°C severe hypothermia.

The impact of hypothermia on the body is related to decreased metabolic and immune activities. The vasoconstriction induced by hypothermia implies a decrease in vascularization of the organs that can cause tissue damage.

These effects explain the role of hypothermia in the pathophysiology of certain perioperative and postoperative complications in the longer term.

Intraoperative hypothermia is responsible for the increase of:

  • 4 times the risk of Surgical Site Infection,
  • twice the risk of cardiovascular morbidity, associated with increased mortality,
  • 33% of transfusion need,
  • 1.5 times the need for continued mechanical ventilation,
  • 3 times the duration of recovering room,
  • twice the hospital stay. This is why hypothermia is responsible for excess perioperative mortality.

According to a 2019 study (Alfonsi P, Bekka S, Aegerter P, SFAR Research Network investigators. Prevalence of hypothermia on admission to recovery room remains high despite a large use of forced-air warming devices: Findings of a non-randomized observational multicenter and pragmatic study on perioperative hypothermia prevalence in France), the prevalence of hypothermia increases from 16.2% of patients before anesthetic induction to 53.5% of patients admitted to the Recovering room. At the end of Recovering room, 33.2% of patients were hypothermic. Among these patients, 15.2% became hypothermic during the recovering room stay.

The risk factors for perioperative hypothermia are multiple:

Patient-related factors: low body mass index; undernutrition; ASA score > 1; pre-existing conditions altering thermoregulation (ex: diabetes with polyneuropathy, hypothyroidism, consumption of sedative or psychoactive drugs); pre-existing hypothermia at surgery.

Factors related to anesthesia techniques: duration of anesthesia > 2 hours; combined general and neuro-axial anesthesia; administration of large volumes of intravenous solutes or transfusion of non-rewarmed globular units.

Factors related to surgery: type, extent and duration of surgery witch use of large amounts of unheated irrigation fluid.

03

Conditions studied

  • Hypothermia; Anesthesia
  • Perioperative/Postoperative Complications
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient undergoing laparoscopic visceral surgery under general anesthesia with transition to recovering room

Exclusion criteria

Exclusion Criteria:

  • Patient undergoing urgent surgery.
  • Presence of pre-existing infection (temperature higher than 38°C when receiving the patient in the hospital ward.
  • Patient with predetermined length of stay in recovering room.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
174 participants (actual)

Study arms

  • Experimental
    RéGlo arm

    Innovative support with global warming strategy.

    Other: global warming

  • Other
    Control arm

    Support according to recommendations

    Other: per operative warming

Interventions

  • Otherglobal warming

    A systematic pre- and post-operative warming associated with the optimization of per-operative warming.

  • Otherper operative warming

    per-operative warming only thanks to the "Optimized" Forced air blanket with a prewarming of 10 minutes performed in the operating room.

06

What researchers measure

Primary outcomes

  1. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the prevalence of hypothermia at the exit of Interventional for patients who underwent laparoscopic visceral surgery.

    Proportion of patients with hypothermia after discharge of recovering room. Hypothermia is defined as a body temperature \< 36°C.

    Time frame: 1 day

Secondary outcomes

  1. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average total mechanical ventilation time

    it is the time between intubation and extubation, expressed in minutes.

    Time frame: 1 day

  2. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average thermal comfort of preoperative patients, on arrival in the pre- anesthesia room

    evaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment)

    Time frame: 1 day

  3. Compare between the experimental group of global warming (RéGlo) and the control group of per- operative warming, the average thermal comfort of preoperative patients, on arrival in the recovering room

    every 15minutes until discharge, evaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment).

    Time frame: 1 day

  4. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the proportion of patients in intraoperative hypothermia

    number of patient with body temperature under 36°C between arrival in pre-operative room and discharge of operating room

    Time frame: 1 day

  5. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 36°C (mild hypothermia)

    expressed in minutes.

    Time frame: 1 day

  6. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 35°C (moderate hypothermia)

    expressed in minutes.

    Time frame: 1 day

  7. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 34°C (severe hypothermia)

    expressed in minutes.

    Time frame: 1 day

  8. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The lowest average temperature reached in °C over the entire management

    the lowest temperture between arrival in the pre-anaesthesia room and exit from recovering room

    Time frame: 1 day

  9. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The proportion of hypothermic patients arriving in recovering room

    number of patient with a temperature below 36°C

    Time frame: 1 day

  10. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average duration of oxygen therapy

    calculated from the introduction of oxygen therapy until its withdrawal in post extubation, regardless of the time of implementation or cessation before resumption of treatment (failure to withdraw oxygen therapy will not be considered), expressed in minutes.

    Time frame: 1 day

  11. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of Nausea or Vomiting Postoperative

    number of patient with Nausea or Vomiting in recovering room evaluated every 15 minutes until discharge

    Time frame: 1 day

  12. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of chills

    number of chills during post-operative monitoring by a Likert scale

    Time frame: 1 day

  13. Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of stirring phase presence

    number of stirring phase evaluated every 15 minutes until discharge

    Time frame: 1 day

  14. The average amount of blood loss per operation

    blood loss measured from the time of entry into the operating theatre to the exit from the operating theatre expressed in millilitres.

    Time frame: 1 day

  15. The average of immediate post-operative blood loss

    blood loss measured in recovering room expressed in millilitres

    Time frame: 1 day

  16. The general average of the thermal variation

    the difference between the patient's lowest and highest temperature between their arrival in the pre-anaesthesia room and their exit from recovering room, expressed in degrees Celsius

    Time frame: 1 day

  17. The average of thermal variation in pre operative

    the difference between the lowest and highest temperature of the patient between the arrival in the waiting room of the operating room and the arrival in the operating room, expressed in degrees Celsius

    Time frame: 1 day

  18. The average thermal variation in per operative

    the difference between the lowest and highest temperature of the patient between the arrival and exit of the operating room, expressed in degrees Celsius

    Time frame: 1 day

  19. the average thermal variation in post operative

    the difference between the lowest and highest temperature of the patient between arrival in and validation exit criteria of recovering room,expressed in degrees Celsius

    Time frame: 1 day

  20. The average length of stay in recovering room

    difference between the time of arrival in recovering room and the time of obtaining the exit criteria , expressed in minutes.

    Time frame: 1 day

07

Study locations

1 site
  • Poitiers University Hospital
    Poitiers, 86000, France
08

References and documents

Publications

  • Alfonsi P, Bekka S, Aegerter P; SFAR Research Network investigators. Prevalence of hypothermia on admission to recovery room remains high despite a large use of forced-air warming devices: Findings of a non-randomized observational multicenter and pragmatic study on perioperative hypothermia prevalence in France. PLoS One. 2019 Dec 23;14(12):e0226038. doi: 10.1371/journal.pone.0226038. eCollection 2019. PubMed 31869333 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Sep 2026, 22 months.

Of 133 non-industry interventional studies with no phase under Hypothermia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 22 months is above that.

Counting every sponsor, half of 136 studies reached it within 16 months; a quarter within 6 and three quarters within 35.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 29, 2026: primary completion Nov 2026 → Sep 2026 and completion Nov 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 9, 2024
First posted
Aug 13, 2024
StartActual
Nov 8, 2024
Primary completionActual
Sep 23, 2026was Nov 2026
CompletionActual
Sep 23, 2026was Nov 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Sep 29, 2026
Primary completion
Nov 2026→Sep 23, 2026 (actual)
Sep 29, 2026
Study completion
Nov 2026→Sep 23, 2026 (actual)
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Recruiting→Completed
    Primary completion Nov 2026→Sep 23, 2026 (now actual)
    Study completion Nov 2026→Sep 23, 2026 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06551558
Responsible party
Sponsor
First posted
Aug 13, 2024
Start date
Nov 8, 2024
Primary completion
Sep 23, 2026
Completion
Sep 23, 2026
Last update
Sep 29, 2026

Study contacts

Matthieu Boisson, Pu-Ph
principal investigator · Poitiers University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion